Asan Medical Center / 서울아산병원
Hospital
Location:
Seoul,
Korea, Republic of (KR)
ISNI: 0000000108422126
ROR: https://ror.org/03s5q0090
Show on Map:
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017)
Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al.
Journal article
Comparison between core-lab and site-read assessment of coronary CT angiography for detection of ischemia-causing lesions: a substudy of the NXT trial (2016)
Marwan M, Gaur S, Leipsic J, Seneviratne S, Ito H, Mauri L, De Bruyne B, et al.
Conference contribution